NYSE:RAD - Rite Aid Stock Price, Price Target & More

$1.57 -0.01 (-0.63 %)

(As of 04/23/2018 01:18 PM ET)

Previous Close$1.58

Today's Range$1.56 - $1.60

52-Week Range$1.38 - $4.28

Volume4.71 million shs

Average Volume24.83 million shs

Market Capitalization$1.69 billion

P/E Ratio-78.50

Dividend YieldN/A

Beta1.8

About Rite Aid (NYSE:RAD)

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. This segment also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; offers integrated mail-order and specialty and compounding pharmacy services; and provides infertility treatment, as well as drug benefits under the federal government's Medicare Part D program. As of June 20, 2017, the company operated approximately 4,500 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores

Sub-IndustryDrug Retail

SectorRetail/Wholesale

SymbolNYSE:RAD

CUSIP76775410

Webwww.riteaid.com

Phone717-761-2633

Debt

Debt-to-Equity Ratio2.11%

Current Ratio1.37%

Quick Ratio0.85%

Price-To-Earnings

Trailing P/E Ratio-78.50

Forward P/E Ratio39.25

P/E GrowthN/A

Sales & Book Value

Annual Sales$21.53 billion

Price / Sales0.08

Cash Flow$0.3121 per share

Price / Cash5.03

Book Value$1.50 per share

Price / Book1.05

Profitability

EPS (Most Recent Fiscal Year)($0.02)

Net Income$943.47 million

Net Margins3.60%

Return on Equity-8.25%

Return on Assets-0.71%

Miscellaneous

Employees87,000

Outstanding Shares1,067,650,000

How to Become a New Pot Stock Millionaire

Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How were Rite Aid's earnings last quarter?

Rite Aid (NYSE:RAD) posted its quarterly earnings data on Thursday, April, 12th. The company reported ($0.01) EPS for the quarter, topping the Zacks' consensus estimate of ($0.02) by $0.01. The company had revenue of $5.39 billion for the quarter, compared to the consensus estimate of $5.75 billion. Rite Aid had a negative return on equity of 8.25% and a net margin of 3.60%. The business's quarterly revenue was down 8.6% compared to the same quarter last year. View Rite Aid's Earnings History.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release their next quarterly earnings announcement on Thursday, July, 5th 2018. View Earnings Estimates for Rite Aid.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid issued an update on its FY19 earnings guidance on Thursday, April, 12th. The company provided EPS guidance of $0.02-0.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.03. The company issued revenue guidance of $21.7-22.1 billion, compared to the consensus revenue estimate of $21.73 billion.

What price target have analysts set for RAD?

8 brokerages have issued 12 month price objectives for Rite Aid's stock. Their forecasts range from $1.50 to $4.70. On average, they expect Rite Aid's share price to reach $2.3063 in the next twelve months. View Analyst Ratings for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a increase in short interest during the month of March. As of March 29th, there was short interest totalling 163,994,755 shares, an increase of 11.9% from the March 15th total of 146,518,471 shares. Based on an average daily volume of 23,947,474 shares, the short-interest ratio is presently 6.8 days. Approximately 15.5% of the shares of the company are sold short.

Who are some of Rite Aid's key competitors?

Some companies that are related to Rite Aid include Michaels Companies (MIK), Sprouts Farmers Market (SFM), Performance Food Group (PFGC), Aaron's (AAN), Tech Data (TECD), PriceSmart (PSMT), Jack in the Box (JACK), Groupon (GRPN), Li-Ning (LNNGY), Boohoo.com (BHOOY), Lithia Motors (LAD), Domino's Pizza Group (DPUKY), Bed Bath & Beyond (BBBY), The Cheesecake Factory (CAKE), Signet Jewelers (SIG), Tempur Sealy International (TPX), Greene King (GKNGY) and Bloomin' Brands (BLMN).

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:

Mr. John T. Standley, Chairman & CEO (Age 55)
Mr. Darren W. Karst, Sr. Exec. VP, CFO & Chief Admin. Officer (Age 58)
Mr. Bryan Everett, Chief Operating Officer of Rite Aid Stores (Age 45)
Mr. Kermit R. Crawford, Pres & COO (Age 59)
Mr. Douglas Elwood Donley, Sr. VP & Chief Accounting Officer (Age 56)

Has Rite Aid been receiving favorable news coverage?

Press coverage about RAD stock has been trending positive this week, according to Accern Sentiment. The research firm identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Rite Aid earned a media sentiment score of 0.25 on Accern's scale. They also gave media headlines about the company an impact score of 44.99 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $1.57.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $1.69 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 87,000 workers across the globe.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]

MarketBeat Community Rating for Rite Aid (RAD)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		375 (Vote Outperform)
Underperform Votes:		372 (Vote Underperform)
Total Votes:		747

MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.

Rite Aid (NYSE:RAD) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

8 Wall Street analysts have issued ratings and price targets for Rite Aid in the last 12 months. Their average twelve-month price target is $2.3063, suggesting that the stock has a possible upside of 46.89%. The high price target for RAD is $4.70 and the low price target for RAD is $1.50. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	1.88	1.88	2.00	2.00
Ratings Breakdown:	2 Sell Rating(s) 5 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 5 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 5 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 5 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$2.3063	$2.3063	$2.7722	$3.3556
Price Target Upside:	46.89% upside	10.88% upside	33.28% upside	88.51% upside

Rite Aid (NYSE:RAD) Consensus Price Target History

Price Target History for Rite Aid (NYSE:RAD)

Rite Aid (NYSE:RAD) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/17/2018	Mizuho	Reiterated Rating	Hold		Medium
1/4/2018	Evercore ISI	Initiated Coverage	Underperform -> Underperform	$1.50	Medium
12/4/2017	Deutsche Bank	Initiated Coverage	Hold	$2.25	Medium
10/25/2017	Royal Bank of Canada	Set Price Target	Hold	$2.00	N/A
10/2/2017	Guggenheim	Reiterated Rating	Neutral	$2.00	Low
9/29/2017	Loop Capital	Reiterated Rating	Hold -> Hold	$2.50 -> $2.00	High
7/3/2017	Cowen	Reiterated Rating	Outperform	$4.70	High
6/30/2017	Bank of America	Reiterated Rating	Underperform	$2.00	High
3/20/2017	Credit Suisse Group	Reiterated Rating	Outperform	$6.50	Low
6/17/2016	JPMorgan Chase	Reiterated Rating	Hold		N/A

(Data available from 4/23/2016 forward)

Rite Aid (NYSE:RAD) Earnings History and Estimates Chart

Earnings by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE:RAD) Earnings Estimates

2018 EPS Consensus Estimate: $0.22

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.03	$0.03	$0.03
Q2 2018	1	$0.04	$0.04	$0.04
Q3 2018	1	$0.08	$0.08	$0.08
Q4 2018	1	$0.07	$0.07	$0.07

Rite Aid (NYSE RAD) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/5/2018
4/12/2018	Q4 2018	($0.02)	($0.01)	$5.7519 billion	$5.3943 billion	View	Listen
9/28/2017	Q2 2018	($0.01)	($0.01)	$7.8286 billion	$7.6789 billion	View	N/A
6/29/2017	Q1 2018	($0.0130)	($0.05)	$8.2902 billion	$7.7815 billion	View	N/A
12/22/2016	Q317	$0.04	$0.02	$8.2296 billion	$8.0897 billion	View	N/A
9/22/2016	Q2	$0.03	$0.03	$8.0860 billion	$8.0298 billion	View	N/A
6/16/2016	Q117	$0.05	$0.01	$8.2312 billion	$8.1842 billion	View	N/A
4/7/2016	Q416	$0.06	$0.07	$8.4680 billion	$8.2701 billion	View	N/A
12/17/2015	Q316	$0.06	$0.06	$8.2016 billion	$8.1542 billion	View	N/A
9/17/2015	Q216	$0.03	$0.02	$7.6014 billion	$7.6648 billion	View	Listen
6/18/2015	Q116	$0.03	$0.04	$6.65 billion	$6.60 billion	View	Listen
4/8/2015	Q415	$0.07	$0.12	$6.7887 billion	$6.85 billion	View	N/A
12/18/2014	Q315	$0.05	$0.10	$6.55 billion	$6.70 billion	View	Listen
9/18/2014	Q215	$0.06	$0.13	$6.4920 billion	$6.5226 billion	View	Listen
6/19/2014	Q115	$0.05	$0.04	$6.43 billion	$6.47 billion	View	Listen
4/10/2014	Q414	$0.04	$0.10	$6.54 billion	$6.60 billion	View	Listen
12/19/2013	Q314	$0.04	$0.04	$6.30 billion	$6.36 billion	View	Listen
9/19/2013	Q2 2014	($0.04)	$0.03	$6.27 billion	$6.30 billion	View	Listen
6/20/2013	Q1 2014	$0.09	$0.09	$6.27 billion	$6.30 billion	View	Listen
4/11/2013	Q4 2013	($0.02)	$0.13	$6.47 billion	$6.50 billion	View	Listen
12/20/2012	Q3 2013	($0.03)	$0.07	$6.28 billion	$6.24 billion	View	Listen
9/20/2012	Q213	($0.07)	($0.05)	$6.20 billion	$6.20 billion	View	N/A
6/21/2012		($0.03)	($0.03)			View	N/A
4/12/2012		($0.17)	($0.18)			View	N/A
12/15/2011		($0.13)	($0.06)			View	N/A
9/22/2011		($0.17)	($0.11)			View	N/A
6/23/2011		($0.12)	($0.07)			View	N/A
4/7/2011		($0.24)	($0.24)			View	N/A
12/16/2010		($0.13)	($0.09)	$6.1981 billion	$6.2020 billion	View	N/A
9/23/2010	Q2 2011	($0.16)	($0.18)			View	N/A
6/23/2010	Q1 2011	($0.14)	($0.09)			View	N/A
3/31/2010	Q4 2010	($0.19)	($0.24)			View	N/A
12/17/2009	Q3 2010	($0.18)	($0.10)			View	N/A
9/24/2009	Q2 2010	($0.15)	($0.14)			View	N/A
6/24/2009	Q1 2010	($0.13)	($0.11)			View	N/A
4/2/2009	Q4 2009	($0.11)	($0.14)			View	N/A
12/18/2008	Q3 2009	($0.17)	($0.17)			View	N/A
9/25/2008	Q2 2009	($0.14)	($0.27)			View	N/A
6/26/2008	Q1 2009	($0.09)	($0.20)			View	N/A
4/10/2008	Q4 2008	($0.07)	($0.07)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Rite Aid (NYSE:RAD) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Rite Aid (NYSE RAD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.29%
Institutional Ownership Percentage: 47.47%

Insider Trading History for Rite Aid (NYSE:RAD)

Institutional Ownership by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE RAD) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/3/2017	Myrtle S Potter	Director	Sell	28,189	$2.09	$58,915.01
6/15/2016	Douglas E Donley	SVP	Sell	34,106	$7.77	$265,003.62	82,885
7/9/2015	Tony Montini	EVP	Sell	353,194	$8.38	$2,959,765.72
4/15/2015	Joseph B Anderson Jr	Director	Sell	150,000	$8.25	$1,237,500.00
4/13/2015	Robert K Thompson	EVP	Sell	95,850	$8.33	$798,430.50
4/10/2015	Douglas E Donley	CAO	Sell	59,404	$8.21	$487,706.84
4/10/2015	Marcy Syms	Director	Sell	150,000	$8.26	$1,239,000.00
12/29/2014	Tony Montini	EVP	Sell	49,525	$7.47	$369,951.75
12/23/2014	Tony Montini	EVP	Sell	259,750	$6.92	$1,797,470.00
12/22/2014	John T Standley	CEO	Sell	1,700,000	$6.82	$11,594,000.00
12/22/2014	Kenneth Martindale	COO	Sell	1,043,400	$6.80	$7,095,120.00
12/22/2014	Robert Ivan Thompson	EVP	Sell	149,231	$6.80	$1,014,770.80
7/3/2014	Robert Ivan Thompson	EVP	Sell	249,583	$7.48	$1,866,880.84
6/24/2014	Joseph B Anderson Jr	Director	Sell	26,667	$7.05	$188,002.35
6/23/2014	Robert Ivan Thompson	EVP	Sell	510,000	$7.06	$3,600,600.00
4/22/2014	Marc Strassler	EVP	Sell	224,800	$7.12	$1,600,576.00	699,369
4/21/2014	Frank Vitrano	EVP	Sell	1,913,925	$7.08	$13,550,589.00	1,183,384
4/16/2014	Robert Ivan Thompson	EVP	Sell	25,566	$7.03	$179,728.98	749,882
2/19/2014	John Standley	CEO	Sell	1,200,000	$6.23	$7,476,000.00	2,974,958
2/19/2014	Kenneth Martindale	COO	Sell	666,667	$6.23	$4,153,335.41	1,193,252
1/21/2014	Douglas Donley	SVP	Sell	24,173	$5.79	$139,961.67	81,628
1/3/2014	John Standley	CEO	Sell	600,000	$5.48	$3,288,000.00	2,974,958
1/3/2014	Kenneth Martindale	COO	Sell	333,333	$5.48	$1,826,664.84	1,193,252
10/18/2013	Robert K Thompson	EVP	Sell	250,000	$5.27	$1,317,500.00
10/17/2013	Douglas E Donley	SVP	Sell	88,700	$5.27	$467,449.00
10/17/2013	Marc A Strassler	EVP	Sell	100,000	$5.31	$531,000.00
10/14/2013	Frank Vitrano	CFO	Sell	1,982,900	$5.00	$9,914,500.00	1,183,384
10/4/2013	Tony Montini	EVP	Sell	414,500	$5.21	$2,159,545.00	643,713
9/25/2013	Robert Ivan Thompson	EVP	Sell	400,000	$4.81	$1,924,000.00	749,882
7/18/2013	Robert K Thompson	EVP	Sell	401,655	$3.01	$1,208,981.55
7/16/2013	David Jessick	Insider	Sell	100,000	$2.93	$293,000.00
7/16/2013	Marc A Strassler	EVP	Sell	375,000	$2.96	$1,110,000.00
7/12/2013	Douglas E Donley	SVP	Sell	6,899	$2.80	$19,317.20
7/11/2013	Douglas E Donley	SVP	Sell	75,378	$2.78	$209,550.84
7/11/2013	Robert Ivan Thompson	EVP	Sell	375,000	$2.75	$1,031,250.00
6/26/2013	Jean Coutu Group (Pjc) Inc.	Major Shareholder	Sell	40,500,000	$2.75	$111,375,000.00

(Data available from 1/1/2013 forward)

Rite Aid (NYSE RAD) News Headlines

Source:

Date	Headline
	$5.35 Billion in Sales Expected for Rite Aid (RAD) This Quarter www.americanbankingnews.com - April 23 at 2:46 AM
	Contrasting Rite Aid (RAD) and Express Scripts (ESRX) www.americanbankingnews.com - April 21 at 5:14 PM
	Naloxone available at Rite-Aid without prescription finance.yahoo.com - April 20 at 3:11 PM
	Rite Aid's Merger Still Makes Sense seekingalpha.com - April 19 at 3:12 PM
	Naloxone Available at Rite Aid Pharmacies in 19 States finance.yahoo.com - April 19 at 3:12 PM
	Rite Aid (RAD) Given Average Recommendation of "Hold" by Brokerages www.americanbankingnews.com - April 18 at 5:30 PM
	Albertsons Companies, LLC -- Moody's assigns B1 CFR to Albertsons Companies, Inc.; outlook negative finance.yahoo.com - April 18 at 3:11 PM
	A Look at Rite Aid’s Fiscal 2019 Guidance finance.yahoo.com - April 18 at 3:11 PM
	Mizuho Reiterates Hold Rating for Rite Aid (RAD) www.americanbankingnews.com - April 18 at 8:42 AM
	What Drove Down Rite Aid’s Fiscal 4Q18 Sales? finance.yahoo.com - April 17 at 3:15 PM
	After Shareholder Backlash, Rite Aid-Albertsons Deal May Get Renegotiated seekingalpha.com - April 16 at 5:57 AM
	Short Interest in Rite Aid (RAD) Increases By 11.9% www.americanbankingnews.com - April 15 at 1:34 AM
	Rite Aid (RAD) Reports Narrower-Than-Estimated Loss in Q4 www.zacks.com - April 13 at 3:15 PM
	Rite Aid: Good News Overlooked seekingalpha.com - April 13 at 3:15 PM
	Rite Aid (RAD) Q4 2018 Earnings Conference Call Transcript finance.yahoo.com - April 13 at 3:15 PM
	Zacks Investment Research Lowers Rite Aid (RAD) to Hold www.americanbankingnews.com - April 13 at 11:45 AM
	Rite Aid's (RAD) CEO John Standley on Q4 2018 Results - Earnings Call Transcript seekingalpha.com - April 13 at 5:21 AM
	Rite Aid Shareholders Sour on Albertsons Deal finance.yahoo.com - April 13 at 5:21 AM
	Rite Aid up 2% on Q4 results; provides guidance seekingalpha.com - April 12 at 3:10 PM
	UPDATE: Rite Aid tops earnings estimates after completing sale of stores to Walgreens www.marketwatch.com - April 12 at 3:10 PM
	Rite Aid misses, UK says Disney must bid for Sky, Tesla’s Model Y to reportedly start production in 2019 finance.yahoo.com - April 12 at 3:10 PM
	Drug retailer Rite Aid's upbeat forecast lifts shares www.reuters.com - April 12 at 3:10 PM
	Rite Aid (RAD) Releases FY19 Earnings Guidance www.americanbankingnews.com - April 12 at 8:55 AM
	Rite Aid (RAD) Issues Earnings Results, Beats Estimates By $0.01 EPS www.americanbankingnews.com - April 12 at 8:55 AM
	Why Rite Aid Short Interest Continues to Climb Ahead of Merger With Albertsons www.msn.com - April 11 at 3:15 PM
	Rite Aid Post Mortem seekingalpha.com - April 10 at 5:17 AM
	Albertsons Withdraws IPO Plan Due To Rite Aid Merger Deal www.nasdaq.com - April 6 at 3:15 PM
	Rite Aid (RAD) Scheduled to Post Earnings on Thursday www.americanbankingnews.com - April 5 at 1:08 AM
	Rite Aid (RAD) Given a $2.00 Price Target by Royal Bank of Canada Analysts www.americanbankingnews.com - April 4 at 9:36 PM
	Albertsons Clears US Antitrust Hurdle in Acquisition of Drugstore Operator Rite Aid www.bloomberg.com - April 3 at 3:09 PM
	Rite Aid-Albertsons Merger Crosses First Antitrust Hurdle www.zacks.com - April 2 at 3:14 PM
	Rite Aid to Release Fourth Quarter Results on April 12 finance.yahoo.com - April 2 at 3:14 PM
	Kroger, Not Albertsons, Should Get Rite Aid seekingalpha.com - April 1 at 3:13 PM
	Rite Aid Co. (RAD) Short Interest Update www.americanbankingnews.com - March 31 at 3:18 AM
	Rite Aid Announces Results of Offer to Purchase Certain of its Outstanding Series of Notes finance.yahoo.com - March 30 at 3:13 PM
	LB-UBS Commercial Mortgage Trust 2006-C6 -- Moody's Affirms Five and Downgrades Two Classes of LBUBS 2006-C6 finance.yahoo.com - March 30 at 5:20 AM
	Rite Aid - Albertsons Deal Gets U.S. Regulatory Approval www.rttnews.com - March 29 at 3:09 PM
	Rite Aid Announces Expiration of Hart-Scott-Rodino Waiting Period for Merger with Albertsons Companies finance.yahoo.com - March 29 at 3:09 PM
	Walgreens: Top Line Grows 12% in Fiscal 2Q18 finance.yahoo.com - March 29 at 3:09 PM
	Rite Aid (RAD) Completes Agreed Store Transfers to Walgreens finance.yahoo.com - March 29 at 3:09 PM
	Rite Aid-Albertsons Deal Clears Key U.S. Antitrust Hurdle finance.yahoo.com - March 29 at 3:09 PM
	ReadyCap Commercial Mortgage Trust 2014-1 -- Moody's Upgrades Three and Affirms Two Classes of RCCMT 2014-1 finance.yahoo.com - March 29 at 3:09 PM
	LB Commercial Mortgage Trust 1999-C1 -- Moody's Upgrades One and Affirms Three Classes of LBCMT 1999-C1 finance.yahoo.com - March 29 at 5:19 AM
	Rite Aid (RAD) Completes Transfer of Stores to Walgreens Boots Alliance (WBA) www.streetinsider.com - March 28 at 3:04 PM
	Rite Aid (RAD) Upgraded to "Strong-Buy" at Vetr www.americanbankingnews.com - March 28 at 12:00 AM
	Walgreens Struggles Despite Being a Healthcare Hub finance.yahoo.com - March 27 at 3:17 PM
	Rite Aid Co. (RAD) Receives Consensus Rating of "Hold" from Analysts www.americanbankingnews.com - March 24 at 5:40 PM
	Will Rite Aid's (RAD) Soft Sales Hurt Earnings Again in Q4? finance.yahoo.com - March 22 at 3:21 PM
	State AG partners with Penguins, Rite Aid foundations to launch prescription-drug safety program www.cnbc.com - March 22 at 1:53 PM
	'Exhausted' Toys 'R' Us suppliers weigh options as huge retailer shuts - Yahoo Finance finance.yahoo.com - March 17 at 3:17 PM

Rite Aid (NYSE:RAD) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Rite Aid (NYSE:RAD) Income Statement, Balance Sheet and Cash Flow Statement

Rite Aid (NYSE RAD) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff